Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1667

    1.

    Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers.

    Yau C, Fedele V, Roydasgupta R, Fridlyand J, Hubbard A, Gray JW, Chew K, Dairkee SH, Moore DH, Schittulli F, Tommasi S, Paradiso A, Albertson DG, Benz CC.

    Breast Cancer Res. 2007;9(5):R59.

    PMID:
    17850661
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    A candidate molecular signature associated with tamoxifen failure in primary breast cancer.

    Vendrell JA, Robertson KE, Ravel P, Bray SE, Bajard A, Purdie CA, Nguyen C, Hadad SM, Bieche I, Chabaud S, Bachelot T, Thompson AM, Cohen PA.

    Breast Cancer Res. 2008;10(5):R88. Epub 2008 Oct 17.

    PMID:
    18928543
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.

    Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson AJ, Strausberg RL, Jat PS, Ashworth A, Neville AM, O'Hare MJ.

    Breast Cancer Res. 2006;8(5):R56.

    PMID:
    17014703
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.

    Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL.

    BMC Genomics. 2006 May 26;7:127.

    PMID:
    16729877
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.

    Pusztai L, Ayers M, Stec J, Clark E, Hess K, Stivers D, Damokosh A, Sneige N, Buchholz TA, Esteva FJ, Arun B, Cristofanilli M, Booser D, Rosales M, Valero V, Adams C, Hortobagyi GN, Symmans WF.

    Clin Cancer Res. 2003 Jul;9(7):2406-15.

    PMID:
    12855612
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer.

    Han W, Han MR, Kang JJ, Bae JY, Lee JH, Bae YJ, Lee JE, Shin HJ, Hwang KT, Hwang SE, Kim SW, Noh DY.

    BMC Cancer. 2006 Apr 12;6:92.

    PMID:
    16608533
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.

    Rody A, Holtrich U, Pusztai L, Liedtke C, Gaetje R, Ruckhaeberle E, Solbach C, Hanker L, Ahr A, Metzler D, Engels K, Karn T, Kaufmann M.

    Breast Cancer Res. 2009;11(2):R15. Epub 2009 Mar 9.

    PMID:
    19272155
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Challenges in projecting clustering results across gene expression-profiling datasets.

    Lusa L, McShane LM, Reid JF, De Cecco L, Ambrogi F, Biganzoli E, Gariboldi M, Pierotti MA.

    J Natl Cancer Inst. 2007 Nov 21;99(22):1715-23. Epub 2007 Nov 13.

    PMID:
    18000217
    [PubMed - indexed for MEDLINE]
    Free Article
    10.

    Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics.

    Jönsson G, Staaf J, Vallon-Christersson J, Ringnér M, Holm K, Hegardt C, Gunnarsson H, Fagerholm R, Strand C, Agnarsson BA, Kilpivaara O, Luts L, Heikkilä P, Aittomäki K, Blomqvist C, Loman N, Malmström P, Olsson H, Johannsson OT, Arason A, Nevanlinna H, Barkardottir RB, Borg A.

    Breast Cancer Res. 2010;12(3):R42. Epub 2010 Jun 24.

    PMID:
    20576095
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    CENP-F expression is associated with poor prognosis and chromosomal instability in patients with primary breast cancer.

    O'Brien SL, Fagan A, Fox EJ, Millikan RC, Culhane AC, Brennan DJ, McCann AH, Hegarty S, Moyna S, Duffy MJ, Higgins DG, Jirström K, Landberg G, Gallagher WM.

    Int J Cancer. 2007 Apr 1;120(7):1434-43.

    PMID:
    17205517
    [PubMed - indexed for MEDLINE]
    12.

    Meta-analysis of breast cancer microarray studies in conjunction with conserved cis-elements suggest patterns for coordinate regulation.

    Smith DD, Saetrom P, Snøve O Jr, Lundberg C, Rivas GE, Glackin C, Larson GP.

    BMC Bioinformatics. 2008 Jan 28;9:63.

    PMID:
    18226260
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    13.

    Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

    Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

    Zentralbl Gynakol. 2006 Apr;128(2):76-81.

    PMID:
    16673249
    [PubMed - indexed for MEDLINE]
    14.

    Meta-analysis and gene set enrichment relative to er status reveal elevated activity of MYC and E2F in the "basal" breast cancer subgroup.

    Alles MC, Gardiner-Garden M, Nott DJ, Wang Y, Foekens JA, Sutherland RL, Musgrove EA, Ormandy CJ.

    PLoS One. 2009;4(3):e4710. Epub 2009 Mar 9.

    PMID:
    19270750
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Clinical validation of a customized multiple signature microarray for breast cancer.

    Tan BK, Tan LK, Yu K, Tan PH, Lee M, Sii LH, Wong CY, Ho GH, Yeo AW, Chow PK, Koong HN, Yong WS, Lim DT, Ooi LL, Soo KC, Tan P.

    Clin Cancer Res. 2008 Jan 15;14(2):461-9.

    PMID:
    18223220
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer.

    Chin SF, Teschendorff AE, Marioni JC, Wang Y, Barbosa-Morais NL, Thorne NP, Costa JL, Pinder SE, van de Wiel MA, Green AR, Ellis IO, Porter PL, Tavaré S, Brenton JD, Ylstra B, Caldas C.

    Genome Biol. 2007;8(10):R215.

    PMID:
    17925008
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Identification of subtypes in human epidermal growth factor receptor 2--positive breast cancer reveals a gene signature prognostic of outcome.

    Staaf J, Ringnér M, Vallon-Christersson J, Jönsson G, Bendahl PO, Holm K, Arason A, Gunnarsson H, Hegardt C, Agnarsson BA, Luts L, Grabau D, Fernö M, Malmström PO, Johannsson OT, Loman N, Barkardottir RB, Borg A.

    J Clin Oncol. 2010 Apr 10;28(11):1813-20. Epub 2010 Mar 15.

    PMID:
    20231686
    [PubMed - indexed for MEDLINE]
    18.

    Array comparative genomic hybridization analysis of genomic alterations in breast cancer subtypes.

    Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, Holcomb IN, Massa HF, Glogovac J, Li CI, Malone KE, Daling JR, Delrow JJ, Trask BJ, Hsu L, Porter PL.

    Cancer Res. 2004 Dec 1;64(23):8541-9.

    PMID:
    15574760
    [PubMed - indexed for MEDLINE]
    Free Article
    19.

    Poor-prognosis estrogen receptor-positive breast cancer identified by histopathologic subclassification.

    Webster LR, Lee SF, Ringland C, Morey AL, Hanby AM, Morgan G, Byth K, Mote PA, Provan PJ, Ellis IO, Green AR, Lamoury G, Ravdin P, Clarke CL, Ward RL, Balleine RL, Hawkins NJ.

    Clin Cancer Res. 2008 Oct 15;14(20):6625-33.

    PMID:
    18927304
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.

    Ihemelandu CU, Leffall LD Jr, Dewitty RL, Naab TJ, Mezghebe HM, Makambi KH, Adams-Campbell L, Frederick WA.

    Ann Surg Oncol. 2007 Oct;14(10):2994-3003. Epub 2007 Jul 24.

    PMID:
    17647064
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk